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-Naphthoﬂavone
nﬂammation
a  b  s  t  r  a  c  t
-Naphthoﬂavone  (-NF),  a ligand  of the  aryl hydrocarbon  receptor,  has  been  shown  to  possess  anti-
oxidative  properties.  We  investigated  the  anti-oxidative  and  anti-inﬂammatory  potential  of  -NF  in
human  microvascular  endothelial  cells  treated  with  tumor  necrosis  factor-alpha  (TNF-).  Pretreatment
with  -NF  signiﬁcantly  inhibited  TNF--induced  intracellular  reactive  oxygen  species, translocation  of
p67phox,  and  TNF--induced  monocyte  binding  and  transmigration.  In  addition,  -NF  signiﬁcantly  inhib-
ited  TNF--induced  ICAM-1and  VCAM-1  expression.  The  mRNA  expression  levels  of the  inﬂammatory
cytokines  TNF-  and  IL-6  were  reduced  by -NF,  as  was  the  inﬁltration  of  white  blood  cells,  in a  peritoni-
tis  model.  The  inhibition  of adhesion  molecules  was  associated  with suppressed  nuclear  translocation
of  NF-B  p65 and  Akt,  and  suppressed  phosphorylation  of ERK1/2  and  p38.  The  translocation  of  Egr-1,  adhesion molecule downstream  transcription  factor  involved  in the MEK-ERK  signaling  pathway,  was  suppressed  by  -NF
treatment.  Our  ﬁndings  show  that  -NF  inhibits  TNF--induced  NF-kB  and  ERK1/2  activation  and  ROS
generation,  thereby  suppressing  the  expression  of adhesion  molecules.  This  results  in  reduced  adhesion
and  transmigration  of  leukocytes  in  vitro  and  prevents  the  inﬁltration  of  leukocytes  in  a peritonitis  model.
Our  ﬁndings  also  suggest  that  -NF  might  prevent  TNF--induced  inﬂammation.
© 2015  The  Authors.  Published  by Elsevier  Ltd.  This  is an  open  access  article  under  the  CC  BY-NC-ND. Introduction
Vascular inﬂammatory responses are modulated by complex
nteractions between circulating leukocytes, tissue-resident leuko-
ytes and the vascular endothelium. Recruitment of leukocytes to
ndothelium depends on the interactions of the endothelial-cell
urface proteins E- and P-selectins with their ligands presented
Abbreviations: -NF, -Naphthoﬂavone; Egr-1, early growth response gene-1;
RK, extracellular signal-regulated kinase; HUVECs, human umbilical vein endothe-
ial cells; ICAM-1, intracellular adhesion molecule-1; LPS, lipopolysaccharide;
CP-1, monocyte chemotactic protein-1; NF-B, nuclear factor-B; TNF-, tumor
ecrosis factor; VCAM-1, vascular cell adhesion molecule-1.
∗ Corresponding author at: Department of Biochemistry, School of Medicine, Tzu
hi  University, Hualien 97004, Taiwan. Fax: +886 3 8580641.
E-mail address: sjjiang@mail.tcu.edu.tw (S.-J. Jiang).
ttp://dx.doi.org/10.1016/j.phrs.2015.10.001
043-6618/© 2015 The Authors. Published by Elsevier Ltd. This is an open access article 
/).license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
on leukocytes. Vascular cell adhesion molecule-1 (VCAM-1) and
intracellular adhesion molecule-1 (ICAM-1) are most prominently
involved in this process [1–3]. Enhanced expression of endothelial
cell adhesion molecules and have been proposed to be related to a
variety of diseases [4–9]. Exposure to pro-inﬂammatory molecules
such as lipopolysaccharide (LPS), tumor necrosis factor-alpha (TNF-
) and interleukin-1  (IL-1) also leads to a signiﬁcant increase in
the expression of adhesion molecules on the surface of endothelial
cells [10–12]. Nuclear factor-B (NF-B) may  also have a stimula-
tory effect on adhesion molecules [13,14], while oxidative stress is
suggested to be another factor that contributes to the regulation of
VCAM-1 [15].Reactive oxygen species (ROS) have a deleterious effect on
vascular functions [16,17]. Superoxide also provokes mono-
cytes to secrete several pro-inﬂammatory factors such as TNF-,
interleukin-6 (IL-6), interleukin-10 (IL-10) and monocyte chemoat-
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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ractant protein-1 (MCP-1), and all these factors are mediators or
odulators of inﬂammatory reactions in the vascular wall [18].
ecent studies on atherosclerosis suggested that the nicotinamide
denine dinucleotide phosphate (NADPH) oxidase enzyme com-
lex of vascular cells plays a critical role in the production of
uperoxide in atherosclerotic lesions [19]. It is essential to decrease
he production of ROS as they are implicated in the pathogenesis
f several diseases.
The compound -naphthoﬂavone (-NF; 5,6-benzoﬂavone) is a
ynthetic derivative of a naturally occurring ﬂavonoid compound.
t is known to strongly upregulate cytochrome P-450 (CYP) 1A
xpression via activation of the aryl hydrocarbon receptor (AhR)
20,21], best known for playing important role in regulating the
oxicity of xenobiotics such as halogenated aromatic hydrocarbons
HAHs) and polycyclic aromatic hydrocarbons (PAHs). Interaction
ith the HAH 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), results
n the AhR-dependent upregulation of several species- and tissue-
peciﬁc toxic and biological responses [22], including the inhibition
f T-cell dependent immune responses [23]. -NF has also been
hown to mitigate dextran sulfate sodium -induced colitis [24].
On the other hand, -NF can increase the expression of a
450-derived arachidonic acid metabolite, 5,6-epoxyeicosatrienoic
cid (EET), which induces hyperpolarization by activation of Ca2+-
ependent K+ channels [25]. It is now known that EETs are
ndothelium-derived hyperpolarizing factors (EDHFs). A recent
eport by Node et al. outlined a new autocrine role for EETs in
ndothelial cells, suggesting they act as anti-inﬂammatory media-
ors [26]. Node et al. reported that EETs are predominant inhibitors
f CAM expression promoted by TNF-, IL-1, and bacterial LPS.
lthough EETs suppressed the expression of VCAM-1, E-selectin,
nd ICAM-1, their effects upon VCAM-1 were the most pronounced.
owever, the effects of -NF on the vasculum remain unclear.
In this study, we demonstrate that -NF reduces the expression
f adhesion molecules in endothelial cells, and decreases mononu-
lear cell adhesion by suppressing NF-B signaling. Our results
uggest that -NF helps to reduce the risk of vascular inﬂamma-
ion by decreasing plasma cytokine release and by directly acting
n the vascular endothelium.
. Materials and methods
.1. Cell culture
The human microvascular endothelial cells HMEC-1 (ATCC, No
RL-10636) was obtained from American Type Culture Collection
Teddington, UK) and cultured in MCDB131 medium containing
ndothelial cell growth supplement (Millipore, Billerica, MA,  USA)
nd 15% fetal bovine serum (FBS), as previously described [27]. The
uman monocytic cell line THP-1 was maintained in RPMI-1640
edium supplemented with 10% FBS.
.2. Cell viability assays
HMEC-1 cells were grown to conﬂuence in 96-well plates. Upon
eaching conﬂuence, medium containing -NF at various concen-
rations was added. After a 48-h incubation, the viability of HMEC-1
ells was determined using a WST-1 assay (Roche, Indianapolis, IN,
SA), according to the manufacturer’s instructions.
.3. Monocyte-HMEC-1 adhesion assays
HMEC-1 cells were grown to conﬂuence in 24-well culture
lates, treated with -NF for 1 h, and then stimulated with 10 ng/ml
NF- for 18 h. THP-1 monocytes were suspended in RPMI 1640
ontaining 0.1% bovine serum albumin (BSA) and labeled with
 M Calcein-AM for 30 min  at 37 ◦C; they were then washed twicesearch 102 (2015) 192–199 193
with Hank’s buffered saline solution (HBSS). Fluorescently labeled
monocytes (2 × 105 cells/well) were then added and incubated with
the -NF-treated HMEC-1 cells for 30 min  at 37 ◦C. Non-adherent
monocytes that had not adhered were removed by gently wash-
ing three times with HBBS. Images of adherent THP-1 cells (5
images/well) were obtained using ﬂuorescence microscopy, with
the number of bound monocytes counted using AlphaImager 2200
software.
2.4. Transendothelial migration
Migration assays were performed in 24-well 6.5-mm diame-
ter trans-well plates containing polycarbonate membranes with
ﬁlters (8-m pore size) (BD Biosciences). Brieﬂy, HMEC-1 cells
cultured on trans-well ﬁlters were pretreated with increasing con-
centrations of -NF for 1 h and stimulated with 10 ng/mL TNF- for
18 h. THP-1 monocytes (2 × 105 cells/well) were added to the upper
chambers of trans-well inserts containing 50 L of RPMI 1640. After
a 4-h incubation at 37 ◦C/5% CO2, cells that had migrated to the
lower chamber were harvested and counted with a microscope. All
experiments were conducted independently at least three times,
with the data representing the mean number of THP-1 cells that
had migrated.
2.5. Measurement of ROS production
Intracellular ROS production was  assessed using 2′,7′-
dicloroﬂuorescein diacetate (H2DCFDA; Invitrogen). HMEC-1
cells were treated with -NF for 1 h and then 10 ng/mL TNF- for
20 min. HMEC-1 cells were incubated with H2DCFDA (10 M)  for
5 min  at 37 ◦C. Images were obtained using a ﬂuorescence micro-
scope (IX-71, Olympus). Fluorescence intensity was measured
using Image J software, averaged, and normalized to the control
value. Three independent experiments were performed.
2.6. Transient transfection and luciferase assays
Endothelial cells were grown to 80% conﬂuence and then tran-
siently transfected with plasmids using Lipofectamine (Invitrogen),
according to the manufacturer’s protocol. Brieﬂy, transfection mix-
tures contained 0.5 g of pGL3-4B-Luc or 0.1 g of pCMV--gal
and were mixed with the Lipofectamine reagent before adding
to cells for 6 h. Cells were washed and fresh medium was  added.
After 18 h, cells were treated with -NF for 1 h and stimulated with
TNF- for 6 h. After cells were lysed, luciferase and -galactosidase
activities were determined using a luciferase assay kit (Promega,
Madison, WI,  USA) according to the manufacturer’s instructions.
Luciferase activity was normalized with respect to -galactosidase
activity and expressed as a percentage of control activity.
2.7. RNA isolation and quantitative polymerase chain reaction
(qPCR) assays
HMEC-1 cells were grown to conﬂuence in 6-cm2 culture plates,
treated with -NF for 1 h, and stimulated with 10 ng/ml TNF-
for 8 h. Total RNA was isolated using Trizol Reagent (Invitrogen),
according to the manufacturer’s suggested protocol. An aliquot
(5 g) of puriﬁed RNA was  reverse transcribed into ﬁrst-strand
complementary DNA (cDNA) with a 2720 Thermal Cycler (Applied
Biosystems, Grand Island, NY, USA), 200 U/L  M-MLV  reverse-
transcriptase (Invitrogen) and 0.5 mg/L oligo(dT)-adapter primers
(Invitrogen) in a 20-L reaction mixture. The qPCR assays for TNF-
, IL-6, and glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
were performed with a Roche LightCycler 480 System (Roche, Indi-
anapolis, IN, USA) and iQ SYBR Green Supermix (Bio-Rad, Hercules,
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Fig. 1. -NF alleviates peritonitis inﬂammation. Cell counts from peritoneal ﬂuid
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Fig. 2. -NF inhibits TNF--induced adhesion of monocytes to HMEC-1 cells and
the  transmigration of monocytes. (A) Adhesion of ﬂuorescent THP-1 monocytes
was  visualized by microscopy and quantiﬁed using AlphaImager. Values are the
mean ± S.D. *P < 0.05 for three independent experiments. (B) THP-1 cells were
allowed to transmigrate through the HMEC-1 monolayer towards a TNF- gradi-
ent. Values are the mean ± S.D. of transmigrated monocytes compared with that of
controls from three independent experiments. *P < 0.05. (C) HMEC-1 cells in 96-well4 h after intraperitoneal injection of thioglycollate in mice are shown. Values are
he  mean ± S.E.M. (n = 10 for control vs.  n = 14 for the -NF treatment). *P < 0.05 vs.
MSO control.
A, USA). The oligonucleotide primers used were speciﬁc for TNF-
 (5′-AGG GAC CTC TCT CTA ATC AG-3′ and 5′-TGG GAG TAG ATG
GG TAC AG-3′), IL-6 (5′-GCC GCC CCA CAC AGA CA-3′ and 5′-CCG
CG AGG ATG TAC CGA AT-3′), and GAPDH (5′-ACG GAT TTG GTC
TA TTG GG-3′ and 5′-TGA TTT TGG AGG GAT CTC GC-3′). Thermal
ycling conditions involved an initial denaturation step at 95 ◦C fol-
owed by 35 ampliﬁcation cycles (15 s at 95 ◦C and 20 s at 60 ◦C) and
ubsequent melt curve analysis (72–98 ◦C). Quantitation of gene
xpression was conducted relative to GAPDH expression levels.
.8. Animals and peritonitis model
The animal experiment was used 8- to 10-week-old male BABL/c
ice to be animal model. These mice were purchased from the
ational Laboratory Animal Breeding and Research Center, Taipei.
he mice were housed in a temperature-controlled, light-cycled
acility and this study was carried out in strict accordance with
he recommendations in the Guide for the Care and Use of Lab-
ratory Animals of the National Institutes of Health. This animal
xperiment performed by Dr. Shih-Yi Peng was allowed by Tzu Chi
niversity Institutional Animal Care and Use Committee (Permit
umber: 101070).
Peritonitis was induced by an intraperitoneal injection of 4%
w/v) thioglycollate in 1 mL  of sterile saline (Sigma–Aldrich, USA).
reatment with DMSO or -NF (20 mg/kg) was performed 1 h
efore the administration of thioglycollate by intravenous admin-
stration. At 24 h after thioglycollate injection, mice were killed by
xposure to CO2, and 5 mL  of HBSS was injected into the peritoneal
avity. Cells were obtained by aspirating peritoneal lavage. Differ-
ntial cell counts were determined using a Hematology Analyzer
KX-21N; Sysmex, USA).
.9. Statistical analysis
Results are expressed as the means ± S.D. from at least
hree independent experiments. Differences between groups were
ssessed by one-way analysis of variance (ANOVA). A P-value less
han 0.05 was considered statistically signiﬁcant.
. Results
.1. Anti-inﬂammatory effects of ˇ-NF on a peritonitis model
n vivo
We  assessed the effects of -NF on inﬂammatory cell recruit-
ent using an acute thioglycollate-induced peritonitis model. At
4 h after thioglycollate stimulation, elicited inﬂammatory cells
ere detected in the peritoneal cavity. Administration of -NF 1 h
efore thioglycollate stimulation signiﬁcantly reduced total white
lood cell inﬁltration in the peritoneal cavity (Fig. 1). Lymphoycte
nﬁltration was also somewhat reduced as a result of -NF treat-
ent.microplate were treated with various concentrations of -NF. After a 48-h incuba-
tion, cell proliferation was evaluated using the colorimetric WST-1 assay. Values are
the  mean ± S.D. from three independent experiments.
3.2. Monocyte adhesion and transmigration of endothelial cells
To test whether -NF inhibits cytokine-mediated vascular
inﬂammation, the effects of -NF on TNF--induced monocyte
adhesion to HMEC-1 cells were assessed. Normal, conﬂuent HMEC-
1 cells bound to THP-1 cells but to a minimal extent. Treatment
with TNF- caused a marked increase in HMEC-1–THP-1 adhesion.
Treatment with -NF decreased the extent of monocyte adhesion
to HMEC-1 cells and was  concentration dependent (Fig. 2A). -
NF at 0.1 M signiﬁcantly reduced the extent of TNF--induced
monocyte adhesion (0.7 ± 0.11-fold vs.  TNF- alone, n = 3, P < 0.05).
The effect of -NF on monocyte transendothelial migration was
studied using trans-well assays. HMEC-1 cells stimulated by TNF-
 exhibited increased levels of monocyte adhesion and migration
across the endothelium as compared to when TNF- was absent. In
contrast, the ability of THP-1 cells to migrate across HMEC-1 cells
was signiﬁcantly decreased to 90% by the presence of -NF, in a
dose-dependent manner (Fig. 2B). These results show that -NF
can inhibit monocytic migration induced by inﬂammation. How-
ever, the inhibitory effects of -NF on monocyte adhesion were
not due to cytotoxicity, as -NF had no effect upon cell viability up
to 48 h (Fig. 2C).
3.3. Effects of ˇ-NF on TNF-˛-induced expression of cell adhesion
molecules
We  examined whether -NF could inhibit TNF--induced
expression of adhesion molecules that mediate leukocyte adhe-
sion to HMEC-1 cells. -NF pretreatment inhibited TNF--induced
expressions of ICAM-1 (1.59 ± 0.18-fold relative to control vs.
1.32 ± 0.04-fold relative to control for 1 M -NF and 1.17 ± 0.07-
fold relative to control for 10 M -NF, n = 3, P < 0.05; Fig. 3)
and VCAM-1 expression (1.53 ± 0.19-fold relative to control vs.
1.29 ± 0.09-fold relative to control for 1 M -NF and 1.19 ± 0.06-
fold relative to control for 10 M -NF, n = 3, P < 0.05; Fig. 3).
3.4. Anti-oxidative effects of ˇ-NF on ROS production and NADPH
oxidase activityROS have been shown to activate various transcription factors in
cultured endothelial cells and have been implicated as a common
second messenger in various pathways leading to NF-B activation.
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Fig. 3. -NF inhibits the expression of TNF--induced adhesion molecules. Pro-
tein  expression levels of ICAM-1 and VCAM-1 were measured by western blotting
with GAPDH used as a loading control as described in supplementary Materials and
Methods. Values are the mean ± S.D. of the protein normalized to GAPDH from three
independent experiments. **P < 0.01 vs.  control and #P < 0.05 vs.  cells stimulated with
TNF-  in the absence of -NF.
Fig. 4. -NF inhibits production of TNF--induced ROS and p67phox membrane
translocation in endothelial cells. (A) ROS production. (B) Immunoﬂuorescence
of p67phox membrane translocation as described in supplementary Materials and
Methods. Fluorescent intensity was quantiﬁed using Image J. Values are the
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Fig. 5. The anti-inﬂammatory effects of -NF are mediated through inhibition of the
NF-B  and ERK-Egr-1 pathways. (A) Expression levels of pIB, pERK, ERK, pAKT,
AKT, pp38, and GAPDH were analyzed by western blotting as described in supple-
mentary Materials and Methods. Results are representative of three independent
experiments. (B) HMEC-1 cells were treated with various concentrations of -NF for
1  h and then stimulated with 10 ng/mL TNF- for 4 h. NF-B p65 was detected using
rabbit anti-p65 and anti-rabbit FITC-conjugated antibodies (green) as described in
supplementary Materials and Methods. Results are representative of three indepen-
dent experiments. Values are the mean ± S.D. from three independent experiments.
*P < 0.05 vs.  control and ##P < 0.01 vs. cells stimulated with TNF- in the absence of -
NF.  (C) Effects of -NF on TNF- induced NF-B luciferase activities were detected.
Values are the mean ± S.D. of relative luciferase activities from three independent
experiments performed in triplicate. *P < 0.05. (D) HMEC-1 cells were treated with
various concentrations of -NF for 1 h, and then stimulated with 10 ng/ml TNF-
for 4 h. Nuclear extracts were harvested, proteins were separated by SDS-PAGE, and
Egr-1 expression levels were determined by western blotting. (E) Cells were ﬁxed
and  stained using an antibody against Egr-1. Translocation of Egr-1 was  determined
by  immunoﬂuorescence. Results shown are from a single experiment, but are rep-
resentative of three separate experiments. Values are the mean ± S.D. from three
* ##ean ± S.D. of ﬂuorescent intensities vs.  control from three independent exper-
ments. *P < 0.05 vs.  control and ##P < 0.01 vs.  cells stimulated with TNF- in the
bsence of -NF.
o determine whether -NF could ameliorate the oxidative stress
nduced by TNF-, the level of intracellular ROS production was
ssessed. Treatment with -NF resulted in a signiﬁcant decrease of
NF--induced ROS production (Fig. 4A). NADPH oxidase in cells
omprises membrane-bound (gp91phox and p22phox) and cytosolic
omponents (p47phox, p67phox, p40phox, and Rac proteins). NADPH
xidase activation requires the membrane translocation of cytoso-
ic components to associate with membrane-bound components
nd assemble into an active enzyme. Immunoﬂuorescence stain-
ng demonstrated that -NF pretreatment of HMEC-1 cells resulted
n a signiﬁcant reduction of membrane expression of p67phox after
NF- stimulation in a dose-dependent manner (Fig. 4B).
.5. Anti-inﬂammatory effects of ˇ-NF by inhibiting NF-B
ctivation
-NF exerted its anti-inﬂammatory effects by inhibiting TNF-
-induced oxidative stress and the expression of cell adhesion
olecules. The upregulation of cell adhesion molecules and activa-
ion of NF-B can be induced by TNF-; therefore, we  investigated
he involvement of NF-B with respect to the anti-inﬂammatory
ffects of -NF in endothelial cells. To determine whether NF-B
ctivation by TNF- is inhibited by treatment with -NF, west-
rn blotting, immunoﬂuorescence staining, and luciferase reporter
ssays were performed. From the total cell lysate, -NF was shownindependent experiments. P < 0.05 vs. control and P < 0.01 vs.  cells stimulated
with  TNF- in the absence of -NF.
to prevent TNF--induced phosphorylation of IB in a dose-
dependent manner (Fig. 5A). In addition, immunoﬂuorescence
analysis revealed that the nuclear translocation of p65, a subunit of
NF-B, and a marker of its activation, was induced by TNF- treat-
ment. However, pretreatment with -NF prevented this activation
in a concentration-dependent manner (Fig. 5B). Transient trans-
fections were performed using an NF-B-dependent luciferase
reporter plasmid to further examine the effects of -NF on NF-B
transcriptional activity. Treatment with TNF- activated NF-B-luc
in endothelial cells, while -NF efﬁciently inhibited TNF--induced
NF-B luciferase activity (Fig. 5C).
Activation of MAP  kinases plays a crucial role during inﬂamma-
tory responses. For example, AP-1 is a redox-sensitive transcription
factor, with the phosphorylation of JNK and ERK occurring prior
to AP-1 activation. We  detected phosphorylation of JNK, p38, and
ERK, and found that phosphorylation levels of ERK and p38 were
increased by TNF-. These increases could be abrogated by -NF
to a certain degree (Fig. 5A). However, -NF had no inﬂuence on
phosphorylation of JNK (data not shown). The anti-inﬂammatory
effects of -NF occurred through the inhibition of NF-B; however,
the involvement of MAP  kinases could not be excluded.
Egr-1, a downstream transcription factor involved in the
MAPK/ERK signaling pathway, was  upregulated by TNF- treat-
ment (Fig. 5D). We  found that pretreatment with -NF reduced
TNF--induced Egr-1 expression to 50% (Fig. 5D). To further
investigate the effects of -NF on Egr-1 signaling, we used
immunoﬂuorescence to examine the nuclear translocation of Egr-
1. Consistent with the expression results, Egr-1 upregulation was
inhibited when HMEC-1 cells were treated with -NF (Fig. 5E).
196 S.-Y. Hsu et al. / Pharmacological Re
Fig. 6. -NF adversely affects the expression of TNF--induced inﬂammatory
cytokines in HMEC-1 cells. Analysis of TNF- and IL-6 mRNA levels were deter-
mined using qPCR assays as described in supplementary Materials and Methods.
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NAPDH cDNA was used as an internal control. Values are the mean ± S.D. of mRNA
evels relative to those for GAPDH from three independent experiments. *P < 0.05 vs.
ontrol and ##P < 0.01 vs.  cells stimulated with TNF- in the absence of -NF.
.6. Inhibitory effects of ˇ-NF on TNF-˛-induced cytokine
ranscription
We  used qPCR assays to quantify the effects of -NF at var-
ous concentrations on the expression of TNF- and IL6 mRNAs
Fig. 6). Compared with control cells, mRNA levels were signiﬁ-
antly increased when endothelial cells were cultured with TNF-.
-NF signiﬁcantly reduced TNF--mediated expression of TNF-
nd IL-6 mRNAs. In addition, there was no signiﬁcant difference
n the mRNA expression levels between -NF-treated and control
ells.
. Discussion
To the best of our knowledge, this study is ﬁrst to show that,
n HMEC-1 cells, -NF, an AhR activator, inhibits TNF--induced
xpression of cell adhesion molecules. Our ﬁndings suggest that
-NF possesses anti-inﬂammatory properties in endothelial cells.
dditionally, we have presented novel evidence to show that the
nhibitory effect of -NF is mediated by ROS, NF-B and ERK1/2-
gr-1 pathways. AhR is a ligand-dependent transcription factor
hat mediates environmental and immunotoxic mechanisms [28].
he anti-inﬂammatory activity of AhR makes it a possible ther-
peutic target for the treatment of autoimmune inﬂammation.
or example, activation of AhR by TCDD reduces inﬂammation
n experimental autoimmune encephalomyelitis (EAE) [29]. AhR
ay  interact directly with NF-kB and IKKs and suppress proin-
ammatory responses [24,30]. Selective AhR regulators can also
how anti-inﬂammatory activity, including alleviation of cytokine-
ediated acute phase genes, as seen in Huh 7 cells [31]. Recently,
ingh et al. showed that AhR activation facilitates epigenetic reg-
lation, thus affecting reciprocal differentiation of Tregs and Th17
ells and alleviating inﬂammation in murine (C57BL/6) colitis [32].
-NF has also been known to alleviate DSS-induced colitis [24].
owever, the activation of AhR does not always correlate with
nti-inﬂammatory effects. Several reports have shown that -NF
ncreases oxidative stress [33,34] and enhances hepatocarcino-
enesis [33,35,36]. The observation that -NF can upregulate the
ytochrome P-450-dependent monooxygenase system has led to
xtensive investigation of -NF as a modiﬁer of chemical car-
inogenesis [37,38]. However, Salmonella/microsome assays have
hown that -NF is not mutagenic, with or without metabolic acti-
ation induced by Aroclor-1254 [39,40]. Lee et al., also reported
hat -NF has no cytotoxic effect on human colon cancer cells
41]. Therefore, -NF can be considered a putative chemopre-
entive agent [42]. Controversially, it has been reported that
-NF may  have hepatocellular tumor-promoting activity as it
ncreases the surface area and number of preneoplastic foci, pos-
tive for placental glutathione S-transferase (GST-P), following
-diethylnitrosamine treatment in rats [35,43]. This increase insearch 102 (2015) 192–199
tumorigenicity is thought to arise due to stimulation of oxidative
stress responses, accompanied by lipid peroxidation and oxida-
tive DNA damage [36,43]. Therefore, the physiological functions
of AhR appear to be complex, exhibiting pro-inﬂammatory or
anti-inﬂammatory characteristics depending on the affected tis-
sue. However, the hepatoma-promoting activity of -NF reported
in previous papers is observed in combination with the car-
cinogenic agent N-diethylnitrosamine, and treatment with -NF
alone does not examine in the situation. In the present study,
we showed that -NF is beneﬁcial in preventing inﬂamma-
tory processes in endothelial cells. The reports on the effects of
-NF provide contradictory ﬁndings and require further investiga-
tion.
Redox regulations in the cell conforms signal transductions that
control metabolism, energetics, survival, and cell death. Reactive
species are known to act as cell signaling molecules, supporting
the double-edged sword of the oxidative stress paradigm in cells
[44,45]. Oxidative stress signiﬁcantly contributes to the pathogen-
esis of cardiovascular disease. The production of ROS (peroxides
and free radicals) is an especially harmful aspect of oxidative stress.
Some of the potential sources of ROS in the vasculature are xanthine
oxidase, NADPH oxidase, and the mitochondria. Several clinical
studies have indicated that enhanced vascular oxidative stress is
strongly related to cardiovascular incidents in patients with coro-
nary artery disease [46]. Vascular NADPH oxidases seem to be the
most signiﬁcant source of ROS in inﬂammatory responses in the
vascular wall, causing the development of vascular wall lesions
[47,48]. Recent progress in our understanding of atherosclerosis
has provided supplementary proof that the NADPH oxidase enzyme
complex plays a critical role in the generation of superoxide in
atherosclerotic lesions [19]. In an earlier study, we have shown
that reduction in the activating subunits of NADPH oxidase, p47
phox and p67 phox, is related to decreased neo-intima formation
after carotid ligation in C57BL/6 mice [49]. In this study, we  have
seen an increase in ROS and NADPH oxidase activity in endothelial
cells treated with TNF-. In cultured cells, addition of NAC, a free
radical scavenger, inhibited TNF--induced ROS levels. This was
an observation that was also made in controls (Fig. 4A). Similarly,
treatment with 10 M -NF again resulted in reduced ROS levels
and NADPH oxidase activity in HMEC-1 cells following TNF- stim-
ulation (Fig. 4A). Flavonoids are predominant inhibitors of NADPH
oxidase activity due to their chemical structure, which comprises
a benzene ring with adjacent methoxy–hydroxyl groups [50]. The
chemical structure of -NF is similar to that of ﬂavonoids and is
likely to have similar inhibitory effects on NADPH oxidase activity.
As shown in our results, -NF has strong anti-oxidative activity and
protects endothelial cells against activation and injury by ROS.
Inﬂammation is one of the factors that increase the risk of
developing cardiovascular disease. The ﬁrst step in the process
of vascular inﬂammation is the adhesion of monocytes to the
endothelium. Subsequently, the monocytes inﬁltrate the endothe-
lial wall and differentiate into macrophages. This critical step is
modulated by interaction between monocytes and the surface
molecules of endothelial cells [51,52]. The expression of cell adhe-
sion molecules, such as VCAM-1 and ICAM-1, mediates monocyte
and macrophage adhesion as well as other processes that initi-
ate atherogenesis [53]. In our current study, we demonstrated
that anti-inﬂammatory effect of -NF is related to fewer mono-
cytes adhering to stimulated endothelial cells and inhibition of
monocyte transendothelial migration (Fig. 2). This occurs when
the expression of adhesion molecules such as ICAM-1 and VCAM-1
is inhibited. As Fig. 3 shows, TNF- slightly increases ICAM-1 and
VCAM-1 expression; however, NF pretreatment decreases TNF-
induced ICAM-1 and VCAM-1 expression. It was reported that NAC
suppresses TNF--stimulated upregulation of adhesion molecules
by decreasing ROS and NF-B activity [54,55]. In addition to this,
ical Re
d
e
t
s
t
w
O
s
a
b
i
n
V
m
l
l
a
e
W
t
t
i

t
w
d
s
a
l
r
c
a
o
f
p
i
t
o
a
u
s
e
A
s
N
r
m
a
t
r
i
k
a
i
i
e
w
a
p
i
P
t
T
pS.-Y. Hsu et al. / Pharmacolog
ecline in ROS levels might further prevent cytokine generation in
ndothelial cells. Treatment with -NF attenuated production of
he pro-inﬂammatory cytokines TNF- and IL-6 following TNF-
timulation (Fig. 6). In our animal model of peritonitis, we  observed
he inhibition of inﬁltration of white blood cells and lymphocytes,
hich conﬁrmed the anti-inﬂammatory properties of -NF (Fig. 1).
ur results are supported by numerous previous studies that have
hown that decreasing intracellular ROS production inhibits the
dhesion of monocytes to endothelial cells [56,57].
The redox-sensitive transcription factor NF-B can be activated
y oxidative stress and participates in the production of pro-
nﬂammatory cytokines [58]. The ROS-mediated NF-B pathway is
eeded for the transcriptional activation of endothelial ICAM-1and
CAM-1 [59]. NF-B activation contributes to the development of
any chronic diseases, especially atherosclerosis [60]. Phosphory-
ated IB- and subsequently nuclear translocation of NF-B p65
ead to the activation of speciﬁc target genes, including ICAM-1
nd VCAM-1. Therefore, we propose that the anti-inﬂammatory
ffects of -NF are due to the inhibition of NF-B activation.
estern blotting analysis and immunoﬂuorescence assays showed
hat pretreatment with -NF inhibited TNF--stimulated nuclear
ranslocation of NF-B p65 (Fig. 5). Consistent with this ﬁnd-
ng, the luciferase reporter assay showed that pretreatment with
-NF attenuated TNF--induced NF-B promoter activity. Oxida-
ive stress enhances NF-B translocation and the decrease that
e observed in NF-B could be a secondary effect of ROS pro-
uction suppressed by -NF [61]. It was discovered that -NF
uppresses the production of TNF--induced ROS, indicating its
nti-inﬂammatory function in the ROS-NF-B pathway in vascu-
ar endothelial cells. The effective concentration of -NF (10 M)
equired to suppress the ROS-NF-B pathway and the effective con-
entration for reducing the expression of cell adhesion molecules
re the same. This ﬁnding is supported by the results from a previ-
us in vitro study that demonstrated free radical scavenging activity
or ﬂavonoids from the fruits of Trema orientalis [62]. Perhaps, the
rotective role of -NF as a free radical scavenger contributes to
ts overall anti-inﬂammatory effects by inhibiting NF-B activa-
ion in vascular endothelial cells. To further conﬁrm whether the
bserved effects are due to AhR-activation rather than direct inter-
ction with and inhibition of NOX, we performed these experiments
sing selective AhR antagonist -Naphthoﬂavone (-NF) and AhR
iRNA [63]. Effect of AhR siRNA on inhibition of AhR expression was
xamined and the result is shown in Supplementary data Fig. S 3.
ccording to the result, AhR siRNA partially inhibited AhR expres-
ion. Effect of -NF on TNF--induced cytokine responses, ROS and
F-kB translocation and effect of -NF on TNF--induced cytokine
esponses, ROS and NF-kB translocation in AhR silicing were esti-
ated as Supplementary data Fig. S4–7. The effect of AhR silencing
lone on TNF--induced various responses was also examined. In
hese experiments, -NF had no effect on TNF--induced cytokine
esponses, ROS, and NF-kB translocation. Meanwhile, AhR silencing
ndeed increased TNF--induced cytokine responses, ROS, and NF-
B translocation in comparison with negative control siRNA. -NF
lso showed inhibitory ability on TNF--induced various responses
n both AhR and negative control silencing since the AhR silencing
s partially. According to these results, we speculate the observed
ffects are due to AhR-activation rather than -NF direct interaction
ith and inhibition of NADPH oxidase in our system.
Other than the NF-B/IB pathway, Akt associated with ERK
nd p38 MAPK plays a signiﬁcant role in the signal transduction
athways that modulate the expression of cell adhesion molecules
n response to external stimuli such as TNF- [64,65]. Moreover,
I3K-Akt and p38 MAPK signaling also contribute to NF-B activa-
ion and increased expression of adhesion molecules in response to
NF- [66,67]. Our results indicate that -NF greatly suppresses the
hosphorylation of Akt, ERK, and p38 MAPK in TNF--stimulatedsearch 102 (2015) 192–199 197
endothelial cells (Fig. 5A). These results demonstrate that the anti-
inﬂammatory effects of -NF are partially due to the inhibition of
adhesion molecules through suppression of ERK, p38, MAPK, and
PI3K-Akt activation.
An early zinc-ﬁnger transcription factor, early growth response
gene-1 (Egr-1), contributes to the formation of atherosclerotic
lesions [68,69]. Its expression is induced in response to various
extracellular stimuli such as growth factors, cytokines, hypoxia,
and other harmful stimuli [70,71]. Egr-1 transcription depends
on the mitogen-activated protein kinase (MAPK)-extracellular
signal-regulated kinase (ERK) signaling (MAPK/ERK) pathway
and serum-response elements of the Egr-1 promoter [72].
Cytokines such as the pro-inﬂammatory cytokine TNF- [73], anti-
inﬂammatory cytokine transforming growth factor- (TGF-)  [74],
and basic ﬁbroblast growth factor (bFGF) [75] also have the Egr-1
sequence in their promoter sites [76]. Additionally, Egr-1 transcrip-
tionally modulates ICAM-1, VCAM-1, and coagulation elements
such as tissue factors [77]. Several factors rapidly increase the
expression of the transcription factor Egr-1 during the progres-
sion of atherosclerosis. Once activated, Egr-1 modulates a variety
of pro-inﬂammatory and pro-atherogenic genes in both mice and
humans [78]. ERK activation upregulates phosphorylation, which
in turn leads to the activation of the transcription factors c-jun, c-
fos, and Egr-1 [79–81]. In our study, the level of stimulus-induced
Egr-1 was  reduced in endothelial cells treated with -NF (Fig. 5D
and E). To our knowledge, this study is the ﬁrst to show that -NF
inhibits TNF--induced expression of VCAM-1 and ICAM-1 through
the suppression of the ERK and Egr-1 signaling pathways. How-
ever, our results do not exclude other transcription factors and
signaling pathways, such as AP-1, SP-1, GATA-2, and IRF-1, that
are also involved in the induction of adhesion molecules [82–85].
These ﬁndings suggest that the suppressive effects of -NF on
stimulus-induced expression of adhesion molecules and on acti-
vation of NF-B and ERK-Egr-1 and Akt signaling might be due to
AhR activation.
5. Conclusion
In summary, our ﬁndings indicate that -NF blocks TNF--
stimulated NADPH oxidase activity and ROS production, alleviates
TNF--induced adhesion molecules expressions and monocyte
binding, and prevents the inﬁltration of white blood cells in a peri-
tonitis model. To the best of our knowledge, we have provided the
ﬁrst evidence of the potential beneﬁts of -NF as a protective agent
against vascular inﬂammation in HMEC-1 cells. Our ﬁndings could
therefore provide new insights into the pathophysiological mech-
anisms with regard to the anti-inﬂammatory properties of -NF in
TNF- induced endothelial stimulation.
Conﬂicts of interest
The authors have declared that there are no conﬂicts of interest.
Acknowledgments
We appreciate the technical assistance provided by Mr.  Hong-
Kai Su and Mr.  Hao-Jhih Yang. This work was  supported by Tzu Chi
University (TCMRC-P-102001 for SJJ) and Tainan Municipal An-Nan
Hospital-China Medical University (ANHRF103-13 for SYH)
Appendix A. Supplementary dataSupplementary data associated with this article can be found,
in the online version, at http://dx.doi.org/10.1016/j.phrs.2015.10.
001.
1 ical Re
R
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[98 S.-Y. Hsu et al. / Pharmacolog
eferences
[1] Y. Jang, A.M. Lincoff, E.F. Plow, E.J. Topol, Cell adhesion molecules in coronary
artery disease, J. Am.  Coll Cardiol. 24 (1994) 1591–1601.
[2] D.T. Price, J. Loscalzo, Cellular adhesion molecules and atherogenesis, Am J.
Med. 107 (1999) 85–97.
[3] T.A. Springer, Trafﬁc signals for lymphocyte recirculation and leukocyte
emigration: the multistep paradigm, Cell 76 (1994) 301–314.
[4] Van Assche G, Rutgeerts P.G. Van Assche, P. Rutgeerts, Physiological basis for
novel drug therapies used to treat the inﬂammatory bowel diseases. I.
Immunology and therapeutic potential of antiadhesion molecule therapy in
inﬂammatory bowel disease, Am.  J. Physiol. Gastrointest. Liver Physiol. 288
(2005) G169–G174.
[5] C.N. Bernstein, M.  Sargent, W.M.  Gallatin, 2 integrin/ICAM expression in
Crohn’s disease, Clin. Immunol. Immunopathol. 86 (1998) 147–160.
[6] M.I. Cybulsky, M.A. Gimbrone Jr., Endothelial expression of a mononuclear
leukocyte adhesion molecule during atherogenesis, Science 251 (1991)
788–791.
[7] S.J. Hwang, C.M. Ballantyne, A.R. Sharrett, L.C. Smith, C.E. Davis, et al.,
Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid
atherosclerosis and incident coronary heart disease cases: the atherosclerosis
risk in communities (ARIC) study, Circulation 96 (1997) 4219–4225.
[8] N. Morisaki, I. Saito, K. Tamura, J. Tashiro, M.  Masuda, et al., New indices of
ischemic heart disease and aging: studies on the serum levels of soluble
intercellular adhesion molecule-1 (ICAM-1) and soluble vascular cell
adhesion molecule-1 (VCAM-1) in patients with hypercholesterolemia and
ischemic heart disease, Atherosclerosis 131 (1997) 43–48.
[9] G. Luc, D. Arveiler, A. Evans, P. Amouyel, J. Ferrieres, et al., Circulating soluble
adhesion molecules ICAM-1 and VCAM-1 and incident coronary heart
disease: the PRIME Study, Atherosclerosis 170 (2003) 169–176.
10] R. Rothlein, M.  Czaijkowski, M.M.  O’Neil, S.D. Marlin, E. Mainolﬁ, et al.,
Induction of intercellular adhesion molecule 1 on primary and continuous cell
lines by pro-inﬂammatory cytokines: regulation by pharmacologic agents and
neutralizing antibodies, J. Immunol. 141 (1998) 1665–1669.
11] M.A. Read, A.S. Neish, F.W. Luscinskas, V.J. Palombella, T. Maniatis, et al., The
proteasome pathway is required for cytokine-induced endothelial-leukocyte
adhesion molecule expression, Immunity 2 (1995) 493–506.
12] G. Haraldsen, D. Kvale, B. Lien, I.N. Farstad, P. Brandtzaeg, Cytokine-regulated
expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and
vascular cell adhesion molecule-1 (VCAM-1) in human microvascular
endothelial cells, J. Immunol. 156 (1996) 2558–2565.
13] E.M. Conner, M.B. Grisham, Inﬂammation, free radicals, and antioxidants,
Nutrition 12 (1996) 274–277.
14] Q. Ruan, Y.H. Chen, Nuclear factor-B in immunity and inﬂammation: the
Treg and Th17 connection, Adv. Exp. Med. Biol. 946 (2012) 207–221, http://
dx.doi.org/10.1007/978-1-4614-0106-3 12.
15] N. Marui, M.K. Offermann, R. Swerlick, C. Kunsch, C.A. Rosen, et al., Vascular
cell  adhesion molecule-1 (VCAM-1) gene transcription and expression are
regulated through an antioxidant-sensitive mechanism in human vascular
endothelial cells, J. Clin. Invest. 92 (1993) 1866–1874.
16] C.A. Papaharalambus, K.K. Griendling, Basic mechanisms of oxidative stress
and  reactive oxygen species in cardiovascular injury, Trends Cardiovasc. Med.
17  (2007) 48–54.
17] K.K. Koh, P.C. Oh, M.J. Quon, Does reversal of oxidative stress and
inﬂammation provide vascular protection? Cardiovasc. Res. 81 (2009)
649–659, http://dx.doi.org/10.1093/cvr/cvn354.
18] Y. Ohara, T.E. Peterson, D.G. Harrison, Hypercholesterolemia increases
endothelial superoxide anion production, J. Clin. Invest. 91 (1993) 2546–2551.
19] D. Sorescu, D. Weiss, B. Lassegue, R.E. Clempus, K. Szocs, et al., Superoxide
production and expression of nox family proteins in human atherosclerosis,
Circulation 105 (2002) 1429–1435.
20] F.P. Guengerich, D.C. Liebler, Enzymatic activation of chemicals to toxic
metabolites, Crit. Rev. Toxicol. 14 (1985) 259–307.
21] H.J. Prochaska, P. Talalay, Regulatory mechanisms of monofunctional and
bifunctional anticarcinogenic enzyme inducers in murine liver, Cancer Res. 48
(1988) 4776–4782.
22] M.S. Denison, S.R. Nagy, Activation of the aryl hydrocarbon receptor by
structurally diverse exogenous and endogenous chemicals, Annu. Rev.
Pharmacol. Toxicol. 43 (2003) 309–334.
23] N.I. Kerkvliet, Immunological effects of chlorinated dibenzo-pdioxins,
Environ. Health Perspect. 103 (1995) 47–53.
24] K. Furumatsu, S. Nishiumi, Y. Kawano, M.  Ooi, T. Yoshie, et al., A role of the
aryl hydrocarbon receptor in attenuation of colitis, Dig. Dis. Sci. 56 (2011)
2532–2544, http://dx.doi.org/10.1007/s10620-011-1643-9.
25] R. Popp, J. Bauersachs, M.  Hecker, I. Fleming, R. Busse, A transferable,
beta-naphthoﬂavone-inducible, hyperpolarizing factor is synthesized by
native and cultured porcine coronary endothelial cells, J. Physiol. 497 (1996)
699–709.
26] K. Node, Y. Huo, X. Ruan, B. Yang, M.  Spiecker, et al., Anti-inﬂammatory
properties of cytochrome P450 epoxygenasederived eicosanoids, Science 285
(1999) 1276–1279.27] D. Kurpios-Piec, E. Grosicka-Macia˛g, K. Woz´niak, C. Kowalewski, E. Kiernozek,
M.  Szumiło, et al., Thiram activates NF-kappaB and enhances ICAM-1
expression in human microvascular endothelial HMEC-1 cells, Pestic.
[
[search 102 (2015) 192–199
Biochem. Physiol. 118 (2015) 82–89, http://dx.doi.org/10.1016/j.pestbp.2014.
12.003.
28] P.K. Mandal, Dioxin a review of its environmental effects and its aryl
hydrocarbon receptor biology, J. Comp. Physiol. 175 (2005) 221–230.
29] F.J. Quintana, A.S. Basso, A.H. Iglesias, T. Korn, M.F. Farez, et al., Control of Treg
and TH17 cell differentiation by the aryl hydrocarbon receptor, Nature 453
(2008) 65–71, http://dx.doi.org/10.1038/nature06880.
30] Y. Tian, A.B. Rabson, M.A. Gallo, Ah receptor and NF-kappaB interactions:
mechanisms and physiological implications, Chem. Biol. Interact. 141 (2002)
97–115.
31] I.A. Murray, C.A. Flaveny, C.R. Chiaro, A.K. Sharma, R.S. Tanos, et al.,
Suppression of cytokine-mediated complement factor gene expression
through selective activation of the Ah receptor with
3’,4’-dimethoxy--naphthoﬂavone, Mol. Pharmacol. 79 (2011) 508–519,
http://dx.doi.org/10.1124/mol.110.069369.
32] N.P. Singh, U.P. Singh, B. Singh, R.L. Price, M.  Nagarkatti, et al., Activation of
aryl  hydrocarbon receptor (AhR) leads to reciprocal epigenetic regulation of
FoxP3 and IL-17 expression and amelioration of experimental colitis, PLoS
One 6 (2011) e23522, http://dx.doi.org/10.1371/journal.pone.0023522.
33] R.H. Elbekai, H.M. Korashy, K. Wills, N. Gharavi, A.O. El-Kadi, Benzo[a]pyrene,
3-methylcholanthrene and beta-naphthoﬂavone induce oxidative stress in
hepatoma hepa 1c1c7Cells by an AHR-dependent pathway, Free Radic. Res. 38
(2004) 1191–1200.
34] J.S. Rhee, Y.M. Lee, B.M. Kim, K.M. Leung, I.C. Kim, et al., -Naphthoﬂavone
induces oxidative stress in the intertidal copepod, Tigriopus japonicus,
Environ. Toxicol. 30 (2015) 332–342, http://dx.doi.org/10.1002/tox.21911.
35] T. Shoda, K. Mitsumori, H. Onodera, K. Toyoda, C. Uneyama, et al., Liver
tumor-promoting effect of beta-naphthoﬂavone, a strong CYP 1A1/2 inducer,
and the relationship between CYP 1A1/2 induction and Cx32 decrease in its
hepatocarcinogenesis in the rat, Toxicol. Pathol. 28 (2000) 540–547.
36] Y. Dewa, J. Nishimura, M.  Muguruma, M.  Jin, M.  Kawai, et al., Involvement of
oxidative stress in hepatocellular tumor-promoting activity of oxfendazole in
rats, Arch. Toxicol. 83 (2009) 503–511, http://dx.doi.org/10.1007/s00204-
008-0349-z.
37] L.W. Wattenberg, Inhibitors of chemical carcinogenesis, Adv. Cancer Res. 26
(1978) 197–226.
38] J. Digiovanni, T.J. Slaga, D.L. Berr, M.K. Juchau, Modiﬁers of chemical
carcinogenesis, in: T.J. Slaga (Ed.), Carcinogenesis, vol. 5, Raven Press, New
York, 1980, pp. 145–168.
39] J.P. Brown, P.S. Dietrich, Mutagenicity of plant ﬂavonols in the
Salmonella/mammalian microsome test: activation of ﬂavonol glycosides by
mixed glycosidases from rat cecal bacteria and other sources, Mutat. Res. 66
(1979) 223–240.
40] D. McKillop, D.E. Case, Mutagenicity, carcinogenicity and toxicity of
-naphthoﬂavone, a potent inducer of P448, Biochem. Pharmacol. 41 (1991)
1–7.
41] J.M. Lee, M.S. Lee, D. Koh, Y.H. Lee, Y. Lim, S.Y. Shin, A new synthetic
2’-hydroxy-2,4,6-trimethoxy-5’,6’-naphthochalcone induces G2/M cell cycle
arrest and apoptosis by disrupting the microtubular network of human colon
cancer cells, Cancer Lett. 354 (2014) 348–354, http://dx.doi.org/10.1016/j.
canlet.2014.08.041.
42] A. Izzotti, M.  Bagnasco, C. Cartiglia, M.  Longobardi, A. Camoirano, et al.,
Modulation of multigene expression and proteome proﬁles by
chemopreventive agents, Mutat. Res. 591 (2005) 212–223.
43] Y. Dewa, J. Nishimura, M.  Muguruma, M.  Jin, Y. Saegusa, et al.,
beta-Naphthoﬂavone enhances oxidative stress responses and the induction
of  preneoplastic lesions in a diethylnitrosamine-initiated
hepatocarcinogenesis model in partially hepatectomized rats, Toxicology 244
(2008) 179–189, http://dx.doi.org/10.1016/j.tox.2007.11.010.
44] A.L. Levonen, B.G. Hill, E. Kansanen, J. Zhang, V.M. Darley-Usmar, Redox
regulation of antioxidants, autophagy, and the response to stress:
implications for electrophile therapeutics, Free Radic. Biol. Med. 71 (2014)
196–207, http://dx.doi.org/10.1016/j.freeradbiomed.2014.03.025.
45] C. Nathan, A. Cunningham-Bussel, Beyond oxidative stress: an immunologist’s
guide to reactive oxygen species, Nat. Rev. Immunol. 13 (2013) 349–361,
http://dx.doi.org/10.1038/nri3423.
46] T. Heitzer, T. Schlinzig, K. Krohn, T. Meinertz, T. Münzel, Endothelial
dysfunction, oxidative stress, and risk of cardiovascular events in patients
with coronary artery disease, Circulation 104 (2001) 2673–2678.
47] E. Schleicher, U. Friess, Oxidative stress, AGE, and atherosclerosis, Kidney Int.
72  (2007) S17–S26.
48] B. Lassègue, K.K. Griendling, NADPH oxidases: functions and pathologies in
the vasculature, Arterioscler. Thromb. Vasc. Biol. 30 (2010) 653–661, http://
dx.doi.org/10.1161/ATVBAHA.108.181610.
49] S.L. Liu, Y.H. Li, G.Y. Shi, S.H. Tang, S.J. Jiang, et al., Dextromethorphan reduces
oxidative stress and inhibits atherosclerosis and neointima formation in mice,
Cardiovasc. Res. 82 (2009) 161–169, http://dx.doi.org/10.1093/cvr/cvp043.
50] P. Mladenka, L. Zatloukalová, T. Filipsky´, R. Hrdina, Cardiovascular effects of
ﬂavonoids are not caused only by direct antioxidant activity, Free Radic. Biol.
Med. 49 (2010) 963–975, http://dx.doi.org/10.1016/j.freeradbiomed.2010.06.
010.51] T.D. Littlewood, M.R. Bennett, Apoptotic cell death in atherosclerosis, Curr.
Opin. Lipidol. 14 (2003) 469–475.
52] L. Piconi, L. Quagliaro, R. Da Ros, R. Assaloni, D. Giugliano, et al., Intermittent
high glucose enhances ICAM-1, VCAM-1, E-selectin and interleukin-6
ical Re
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
activator of vascular cell adhesion molecule 1, Mol. Cell Biol. 15 (1995)
2558–2569.
[85] K.A. Roebuck, Oxidant stress regulation of IL-8 and ICAM-1 gene
expression:differential activation and binding of the transcription factorsS.-Y. Hsu et al. / Pharmacolog
expression in human umbilical endothelial cells in culture: the role of
poly(ADP-ribose) polymerase, J. Thromb. Haemost. 2 (2004) 1453–1459.
53] M.,  Trerotola, E., Guerra, S., Alberti. Letter to the editor: efﬁcacy and safety of
anti-Trop antibodies, R., Cubas, M.,  Li, C. Chen and Q. Yao, Biochim Biophys
Acta 1796 (2009) 309-1. Biochim Biophys Acta 2010;1805: 119-120. doi:
10.1016/j.bbcan.2009.12.002.
54] S. Sakurada, T. Kato, T. Okamoto, Induction of cytokines and ICAM-1 by
proinﬂammatory cytokines in primary rheumatoid synovial ﬁbroblasts and
inhibition by N-acetyl-L-cysteine and aspirin, Int. Immunol. 8 (1996)
1483–1493.
55] M.  Zafarullah, W.Q. Li, J. Sylvester, M.  Ahmad, Molecular mechanisms of
N-acetylcysteine actions, Cell Mol. Life Sci. 60 (2003) 6–20.
56] S.J. Lin, S.K. Shyue, Y.Y. Hung, Y.H. Chen, H.H. Ku, et al., Superoxide dismutase
inhibits the expression of vascular cell adhesion molecule-1 and intracellular
cell adhesion molecule-1 induced by tumor necrosis factor-alpha in human
endothelial cells through the JNK/p38 pathways, Arterioscler. Thromb. Vasc.
Biol. 25 (2005) 334–340.
57] A. Paine, B. Eiz-Vesper, R. Blasczyk, S. Immenschuh, Signaling to heme
oxygenase-1 and its anti-inﬂammatory therapeutic potential, Biochem.
Pharmacol. 80 (2010) 1895–1903, http://dx.doi.org/10.1016/j.bcp.2010.07.
014.
58] M.E. Pueyo, W.  Gonzalez, A. Nicoletti, F. Savoie, J.F. Arnal, et al., Angiotensin II.
stimulates endothelial vascular cell adhesion molecule-1 via nuclear
factor-kappaB activation induced by intracellular oxidative stress,
Arterioscler. Thromb. Vasc. Biol. 20 (2000) 645–651.
59] T. Collins, M.A. Read, A.S. Neish, M.Z. Whitley, D. Thanos, et al., Transcriptional
regulation of endothelial cell adhesion molecules: NF-kappa B and
cytokine-inducible enhancers, FASEB J. 9 (1995) 899–909.
60] E.S. Biegelsen, J. Loscalzo, Endothelial function and atherosclerosis, Coron.
Artery Dis. 10 (1999) 241–256.
61] R. Schreck, P. Rieber, P.A. Baeuerle, Reactive oxygen intermediates as
apparently widely used messengers in the activation of the NF-kB
transcription factor and HIV-1, EMBO J. 10 (1991) 2247–2258.
62] G.H. Xu, I.J. Ryoo, Y.H. Kim, S.J. Choo, I.D. Yoo, Free radical scavenging and
antielastase activities of ﬂavonoids from the fruits of Thuja orientalis, Arch.
Pharm. Res. 32 (2009) 275–282, http://dx.doi.org/10.1007/s12272-009-1233-
y.
63] A. Jacob, S. Potin, H. Chapy, D. Crete, F. Glacial, K. Ganeshamoorthy, et al., Aryl
hydrocarbon receptor regulates CYP1B1 but not ABCB1 and ABCG2 in
hCMEC/D3 human cerebral microvascular endothelial cells after TCDD
exposure, Brain Res. 1613 (2015) 27–36, http://dx.doi.org/10.1016/j.brainres.
2015.03.049.
64] J.W. Ju, S.J. Kim, C.D. Jun, J.S. Chun, p38 kinase and c-Jun N-terminal kinase
oppositely regulates tumor necrosis factor alphainduced vascular cell
adhesion molecule-1 expression and cell adhesion in chondrosarcoma cells,
IUBMB Life 54 (2002) 293–299.
65] A.W. Ho, C.K. Wong, C.W. Lam, Tumor necrosis factor-alpha up-regulates the
expression of CCL2 and adhesion molecules of human proximal tubular
epithelial cells through MAPK signaling pathways, Immunobiology 213
(2008) 533–544, http://dx.doi.org/10.1016/j.imbio.2008.01.003.
66]  J.S. Kang, Y.D. Yoon, M.H. Han, S.B. Han, K. Lee, et al., Glabridin suppresses
intercellular adhesion molecule-1 expression in tumor necrosis
factor-alpha-stimulated human umbilical vein endothelial cells by blocking
sphingosine kinase pathway: implications of Akt, extracellular
signal-regulated kinase, and nuclear factor-kappaB/Rel signaling pathways,
Mol. Pharmacol. 69 (2006) 941–949.
67] S.F. Luo, R.Y. Fang, H.L. Hsieh, P.L. Chi, C.C. Lin, et al., Involvement of MAPKs
and  NF-kappaB in tumor necrosis factor alpha-induced vascular cell adhesion
molecule 1 expression in human rheumatoid arthritis synovial ﬁbroblasts,
Arthr. Rheum. 62 (2010) 105–116, http://dx.doi.org/10.1002/art.25060.
68] T.A. McCaffrey, C. Fu, B. Du, S. Eksinar, K.C. Kent, et al., High-level expression
of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis, J.
Clin. Invest. 105 (2000) 653–662.search 102 (2015) 192–199 199
69] L.M. Khachigian, Early growth response-1 in cardiovascular pathobiology,
Circ. Res. 98 (2006) 186–191.
70] F. Bea, E. Blessing, M.I. Shelley, J.M. Shultz, M.E. Rosenfeld, Simvastatin
inhibits expression of tissue factor in advanced atherosclerotic lesions of
apolipoprotein E deﬁcient mice independently of lipid lowering: potential
role of simvastatin mediated inhibition of Egr-1 expression and activation,
Atherosclerosis 167 (2003) 187–194.
71] E. Blessing, M.R. Preusch, R. Kranzho¨ fer, R. Kinscherf, N. Marx, et al.,
Antiatherosclerotic properties of telmisartan in advanced atherosclerotic
lesions in apolipoprotein E deﬁcient mice, Atherosclerosis 199 (2008)
295–303.
72] M.  Kamimura, C. Viedt, A. Dalpke, M.E. Rosenfeld, N. Mackman, et al.,
Interleukin-10 suppresses tissue factor expression in
lipopolysaccharidestimulated macrophages via inhibition of Egr-1 and a
serum response element/MEKERK1/2 pathway, Circ. Res. 97 (2005) 305–313.
73] B. Kramer, A. Meichle, G. Hensel, P. Charnay, M.  Kronke, Characterization of a
Krox-24/ Egr-1-responsive element in the human tumor necrosis factor
promoter, Biochem. Biophys. Acta 1219 (1994) 413–421.
74] B.R. Dey, V.P. Sukhatme, A.B. Roberts, M.B. Sporn, F.J. Rauscher 3rd, et al.,
Repression of the transforming growth factor-beta 1 gene by the Wilms’
tumor suppressor WT1  gene product, Mol. Endocrinol. 8 (1994) 595–602.
75] E. Biesiada, M.  Razandi, E.R. Levin, Egr-1 activates basic ﬁbroblast growth
factor transcription. mechanistic implications for astrocyte proliferation, J.
Biol.  Chem. 271 (1996) 16576–16581.
76] J.S. Maltzman, J.A. Carman, J.G. Monroe, Transcriptional regulation of the
ICAM-1 gene in antigen receptor- and phorbol ester-stimulated B
lymphocytes: role for transcription factor Egr-1, J. Exp. Med. 183 (1996)
1747–1759.
77] M.-Z. Cui, G.C.N. Parry, P. Oeth, H. Larson, M.  Smith, et al., Transcriptional
regulation of the tissue factor gene is mediated by SP1 and EGR-1, J. Biol.
Chem. 271 (1996) 2731–2739.
78] F. Blaschke, D. Bruemmer, R.E. Law, Egr-1 is a major vascular pathogenic
transcription factor in atherosclerosis and restenosis, Rev. Endocr. Metab.
Disord. 5 (2004) 249–254.
79] M.  Zhang, C. Miller, Y. He, J. Martel-Pelletier, J.P. Pelletier, et al., Calphostin C.
induces AP1 synthesis and AP1-dependent c-jun transactivation in normal
human chondrocytes independent of protein kinase C-alpha inhibition:
possible role for c-jun N-terminal kinase, J. Cell Biochem. 76 (1999) 290–302.
80] M.  Guha, M.A. O’Connell, R. Pawlinski, A. Hollis, P. McGovern, et al.,
Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human
monocytic cells mediates tissue factor and tumor necrosis factor—a
expression by inducing Elk-1 phosphorylation and Egr-1 expression, Blood 98
(2001) 1429–1439.
81] A. Sodhi, G. Sethi, Involvement of MAP  kinase signal transduction pathway in
UVB  induced activation of macrophages in vitro, Immunol. Lett. 90 (2003)
123–130.
82] M.F. Iademarco, J.J. McQuillan, G.D. Rosen, D.C. Dean, Characterization of the
promoter for vascular cell adhesion molecule1 (VCAM-1), J. Biol. Chem. 267
(1992) 16323–16329.
83] A.S. Neish, L.M. Khachigian, A. Park, V.R. Baichwal, T. Collins, Sp1 is a
component of the cytokine-inducible enhancer in the promoter of vascular
cell adhesion molecule-1, J. Biol. Chem. 270 (1995) 28903–28909.
84] A.S. Neish, M.A. Read, D. Thanos, R. Pine, T. Maniatis, et al., Endothelial
interferon regulatory factor 1 cooperates with NFkappa B as a transcriptionalAP-1 and NF-kB, Int. J. Mol. Med. 4 (1999) 223–230.
